09.10.15
Batesville, Ind.-based Rom Holdings Inc. has completed the $2.05 billion acquisition of Welch Allyn, maker of medical diagnostic devices, patient monitoring systems and miniature precision lamps. Hill-Rom makes hospital furniture, medical equipment, and a variety of medical technologies. Under the terms of the agreement, Welch Allyn shareholders received $1.625 billion in cash and approximately 8.1 million newly-issued shares of Hill-Rom common stock.Vie
Through the acquisition of Welch Allyn, Hill-Rom expects to play an even greater role in improving patient care globally and achieving greater levels of efficiency and reducing health care costs for its customers. Combining Hill-Rom’s position in hospitals and operating rooms worldwide with Welch Allyn’s position in point of care diagnostics and testing will expand both companies’ ability to help health care providers focus on patient care solutions that improve clinical and economic outcomes. Together, Hill-Rom and Welch Allyn will offer a wide range of innovative solutions to a patient-centric, global customer base focused on quality and efficiency.
“We are excited to officially welcome our 2,500 Welch Allyn colleagues to the Hill-Rom family,” said John J. Greisch, president and CEO of Hill-Rom. “Our companies share similar legacies of innovation, quality and employees who are passionate about enhancing outcomes for patients and caregivers.”
The acquisition of Welch Allyn is not expected to be materially accretive to Hill-Rom’s fiscal 2015 earnings. For fiscal 2016, beginning Oct. 1, the transaction is expected to add over 10 percent to adjusted earnings per share, and to be accretive on a meaningfully higher basis thereafter. It is being funded by a combination of cash on hand, and new equity and debt issuances.
Through the acquisition of Welch Allyn, Hill-Rom expects to play an even greater role in improving patient care globally and achieving greater levels of efficiency and reducing health care costs for its customers. Combining Hill-Rom’s position in hospitals and operating rooms worldwide with Welch Allyn’s position in point of care diagnostics and testing will expand both companies’ ability to help health care providers focus on patient care solutions that improve clinical and economic outcomes. Together, Hill-Rom and Welch Allyn will offer a wide range of innovative solutions to a patient-centric, global customer base focused on quality and efficiency.
“We are excited to officially welcome our 2,500 Welch Allyn colleagues to the Hill-Rom family,” said John J. Greisch, president and CEO of Hill-Rom. “Our companies share similar legacies of innovation, quality and employees who are passionate about enhancing outcomes for patients and caregivers.”
The acquisition of Welch Allyn is not expected to be materially accretive to Hill-Rom’s fiscal 2015 earnings. For fiscal 2016, beginning Oct. 1, the transaction is expected to add over 10 percent to adjusted earnings per share, and to be accretive on a meaningfully higher basis thereafter. It is being funded by a combination of cash on hand, and new equity and debt issuances.